INFARMA SERVICIOS FARMACEUTICOS SL
Company details
- Defunct NIF/CIF: B81272304
-
-
-
-
Address: Not available
-
-
Featured products:
More information on INFARMA SERVICIOS FARMACEUTICOS SL
-
27/12/2007 | BORME act no.: 645517 | Register: MADRIDCeses/Dimisiones
-
27/12/2007 | BORME act no.: 645517 | Register: MADRIDNombramientos
-
27/12/2007 | BORME act no.: 645517 | Register: MADRIDDisolución
-
03/12/2007 | BORME act no.: 1113248 | Register: MADRIDDepósito de cuentas anuales (Noviembre de 2007)
-
05/01/2007 | BORME act no.: 30101 | Register: MADRIDDepósito de cuentas anuales (Diciembre de 2006)
-
25/11/2002 | BORME act no.: 810858 | Register: MADRIDDepósito de cuentas anuales (noviembre de 2002)
-
04/10/2001 | BORME act no.: 414162 | Register: MADRIDDepósito de cuentas anuales (julio de 2001)
-
29/11/2000 | BORME act no.: 702005 | Register: MADRIDDepósito de cuentas anuales (agosto de 2000)
Other information
The CIF of INFARMA SERVICIOS FARMACEUTICOS SL is B81272304 and its business status is defunct. Its economic activity belongs to the CNAE 6420 - Holding company activities. Its SIC is -.
INFARMA SERVICIOS FARMACEUTICOS SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Madrid. It has a total of 2 registration charges. Its latest announcement in Borme was published on 27/12/2007 and its last deposit of ordinary annual accounts is from the year -.
You can check the contact details of INFARMA SERVICIOS FARMACEUTICOS SL such as phone number, address, or website in the Company Data module.
For more information about INFARMA SERVICIOS FARMACEUTICOS SL, you can acquire one of our available financial reports, the Annual Accounts of the company, or check its payment incidents in the RAI delinquency file.
All the financial, business, and legal information we provide about INFARMA SERVICIOS FARMACEUTICOS SL comes from official sources and is updated daily.
Do you want to know more about INFARMA SERVICIOS FARMACEUTICOS SL??
Find out more about this company by consulting these reports: